OraSure Technologies (OSUR) granted FDA approval for OraQuick In-Home HIV test - Bloomberg

Go back to OraSure Technologies (OSUR) granted FDA approval for OraQuick In-Home HIV test - Bloomberg
OraSure Technologies, Inc. (NASDAQ: OSUR) Delayed: 3.94 -0.08 (1.99%)
Previous Close $4.02    52 Week High $9.05 
Open $4.02    52 Week Low $5.10 
Day High $4.02    P/E N/A 
Day Low $3.84    EPS $-0.20 
Volume 243,554